In a 67-child open-label trial, preschoolers with cystic fibrosis who switched from Trikafta to Alyftrek saw sweat chloride fall further, with 65% reaching normal levels.
Two Thirds of Preschoolers Switched to Alyftrek Reached Normal Sweat Chloride in Small Cystic Fibrosis Trial
by | Sep 14, 2026 | Uncategorized | 0 comments
Recent Comments